Greenfield Savings Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Sell
9,837
-36
-0.4% -$4.74K 0.47% 53
2026
Q1
$1.38M Buy
9,873
+331
+3% +$46.4K 0.59% 48
2025
Q4
$1.17M Buy
9,542
+686
+8% +$83.4K 0.49% 54
2025
Q3
$983K Buy
8,856
+1,409
+19% +$160K 0.41% 62
2025
Q2
$826K Buy
7,447
+1,148
+18% +$122K 0.37% 73
2025
Q1
$706K Buy
6,299
+159
+3% +$16.4K 0.35% 81
2024
Q4
$567K Sell
6,140
-560
-8% -$50.4K 0.27% 94
2024
Q3
$562K Sell
6,700
-533
-7% -$40.7K 0.27% 97
2024
Q2
$496K Sell
7,233
-8,733
-55% -$583K 0.26% 94
2024
Q1
$1.17M Buy
15,966
+123
+0.8% +$9.46K 0.61% 51
2023
Q4
$1.28M Sell
15,843
-70
-0.4% -$5.45K 0.74% 44
2023
Q3
$1.19M Sell
15,913
-255
-2% -$19.6K 0.75% 44
2023
Q2
$1.25M Sell
16,168
-544
-3% -$43.4K 0.84% 37
2023
Q1
$1.39M Buy
16,712
+823
+5% +$68.2K 0.9% 36
2022
Q4
$1.36M Buy
15,889
+179
+1% +$14.2K 0.9% 38
2022
Q3
$969K Sell
15,710
-362
-2% -$22.8K 0.7% 46
2022
Q2
$993K Buy
+16,072
New +$995K 0.67% 53

Other funds holding GILD

Greenfield Savings Bank's GILD Position: Q2 2026 in Review

Greenfield Savings Bank reduced its Gilead Sciences (GILD) stake by 0.36% in Q2 2026, selling an estimated $4.74K and leaving 9,837 shares worth $1.24M. The position accounts for 0.47% of the portfolio, ranked #53.

Greenfield Savings Bank first reported a position in GILD in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.39M in Q1 2023. 1,146 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Greenfield Savings Bank held 9,837 shares of Gilead Sciences worth $1.24M as of Q2 2026.
  • Greenfield Savings Bank sold 36 Gilead Sciences shares in Q2 2026, an estimated $4.74K.
  • Gilead Sciences made up 0.47% of Greenfield Savings Bank's portfolio in Q2 2026, its #53 holding.
  • Greenfield Savings Bank first reported a position in Gilead Sciences in Q2 2022 and has held it in 17 quarters since.
  • Greenfield Savings Bank's Gilead Sciences position peaked at $1.39M in Q1 2023.
  • 1,146 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Greenfield Savings Bank's 13F filing for Q2 2026, filed 7 Jul 2026.